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Abstract
Background. Appropriate clinical assessment of pain in cancer patients is a necessary requirement for
establish an adequate pain management. Quality of life in the terminally ill cancer patients is used to measure
as well as to show direction of operation of therapeutic group.
Material and methods. In the period from July 2006 to July 2007 in the Department of Chronic Pain
Treatment, Palliative Care and Clinical Pharmacology of the Jagiellonian University Medical College a group of
34 patients in the terminal phase of cancer were analyzed. Intensity of experienced pain was measured with
Numeric Rating Scale (NRS) and Verbal Rating Scale (VRS). Fear, depression and aggression occurrence was
measured with HADS — M scale. By the use of Rotterdam List general evaluation of quality of life and
individual dimensions of quality of life.
Results. Statistically significant relation between cancer pain intensity level measured and individual dimen-
sions of quality of life.
Conclusions. Our results confirmed the presence of warning a relation between intensity of pain and quality
of life. They have called attention on problems of pain in a multi-directional manner and take many aspects
into consideration, in order to improve care and quality of life.
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Introduction
From literature reports we know that 9 millions
of sick people in the world suffers because of can-
cer pain. In consequence of this pain many people
have to endure lowering — to a great extent — the
quality of their life [1].
In Poland, over 80 thousands people died that
year of malignant tumors which present nearly 20%
of all reasons of death [2].
According to the definition of International As-
sociation Study of Pain (IASP) pain is an unpleasant
sensory and emotional experience which accompa-
nies existing or threatening tissue damage or it is
only associated with such damage [3–6].
In cancer disease pain is called total pain (all-
embracing) which — according to Twycross and Lack
— originates not only from somatic factors, but also
from anxiety, depression, lowered spirits, and it calls
for a more holistic approach to so complex symp-
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toms. Research indicates that frequency of occur-
rence of pain attacks grows with the progress of
disease and that intensity, character and localization
of pain depend on localization of cancer seat, and a
degree of advance and progress of the disease [7, 8].
Pain occurs in 30–40% of patients subjected to
oncological therapy and in 70–90% of patients with
advanced cancer disease [9, 10].
In the terminal period when procedures acting
directly on causes of the disease are completed,
several kinds of pain of a high degree of intensity
are observed, and over 80% of patients report suf-
fering from two or more, and over 30% of patients
from four or more kinds of pain [11].
Pain in cancer patients can be divided into fol-
lowing categories:
— pain resulting from disease progress;
— pain resulting from treatment;
— pain from cancerous cachexia;
— pain related to infirmity (coincidental) [8].
Evaluation of pain is important not only in its
diagnosing, but also in evaluation of the efficiency
of method of pain control, quality of patients’ life
and quality of palliative care. Proper recognition of
etiology and kind of chronic pain allows for correc-
tion of the efficiency of therapy and for  improve-
ment of palliative procedures [12]. It is especially
important in treatment of pain in the terminal peri-
od, in order to blot out suffering from memory in
an effective way and to warrant conditions of dig-
nified dying. Palliative care is directed on ameliora-
tion of quality of life of patients and their families.
It brings relief by applying of proper means of re-
ducing suffering accompanying the life-threaten-
ing disease and it ensures competent control of
individual symptoms [13].
Phenomenon of pain presents an important cat-
egory of human experience, consisting of somatic
and psychical components which build up emotion-
al/motivating and cognitional/valuating elements.
Differentiation of individual components allows for
determination of relationship between pain and
quality of life.
A degree of release from pain is an individual
phenomenon, but at the same time it is necessary
to obtain a sufficiently comfortable level of quality
of life [14].
In the subject literature one can observe grow-
ing interest in problems of quality of life of ill peo-
ple, and — particularly — cancer patients [15].
However, rather seldom quality of life is de-
scribed in patients with chronic pain in the termi-
nal period when they intensely suffer from somat-
ic complaints, reduction of physical fitness, wors-
ening of social relations and differentiation of psy-
chical reactions. This is why the studies should be
undertaken aiming at widening and deepening of
research in terminally-ill patients suffering from
chronic pain, in order to improve quality of their
life in this period.
Purpose of work
The aim of work was:
— evaluation of a level of quality of life and its indi-
vidual components in patients with cancer pain;
— determination of a relationship between inten-
sity of pains and individual dimensions of quali-
ty of life;
— evaluation of intensifying of pain on individual
periods of research;
— evaluation of the influence of  treatment on suf-
fering of pain.
Material and methods
Thirty-four terminal-stage cancer patients hos-
pitalized in the Department of Chronic Pain Treat-
ment, Palliative Care and Clinical Pharmacology of
the Jagiellonian University Medical College were in-
cluded into the study which was carried-out during
the period between July 2006 and July 2007. The
study comprised patients of both sexes, and their
age ranged from 25–75 years, average 56.3 (±
12.09), with following  types of neoplastic disease:
cancer, sarcoma, leukemia, lymphoma, melanoma.
The trial was conducted in accordance with the
Declaration of Helsinki and informed consent was
obtained from each patient. It was granted the
agreement of the Commission of Bioethics of the
Jagiellonian University to conduct  research on pa-
tients with chronic pains (KBET/98/B/2006). In view
of the fact that research was carried out on patients
in terminal stage of cancer disease, consideration
was also given to observing law contained in the
Venetian Declaration on  terminal stages, of the
year 1983. The condition of qualification for research
was to obtain written agreement and an indication
with diagnosis of cancer disease in the stage of
metastases definitely stating completion of causal
treatment and beginning of symptomatic treatment
in the Department of Palliative Care.
In accordance with guidelines of the Interna-
tional Association of Pain Research in patients with
cancer pains the study did not take into consider-
ation duration of pain in the period before hospital-
ization of patients [6]. Before beginning of the study,
Cognitive Assessment Scale (CAS) was applied in
patients. It was accepted that the study would in-
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clude persons without (CAS 12–11) and with mild
(CAS 10–8) cognitive disturbances who were able
to evaluate self-dependently the effectiveness of pal-
liative care.
With respect to chronic somatic disease, research
study was divided into 3 periods: The first period
comprised acceptance in the hospital, next two pe-
riods were as follows: one week and then two weeks
of hospitalization.
Application of the above time schedule allowed
to present chronic disease as a process which takes
into consideration subjective evaluation of a state
of health through individual dimensions. Patients
in which cancer process caused considerable handi-
caps of cognitive functions (CAS £ 7) and those
who underwent sudden deterioration of  health have
been excluded from the study.
Research material has been collected  employ-
ing following instruments: Numeric scale (NRS —
Numeric Rating Scale), serving for estimation of pain.
This scale — consisting of numbers from 0 to 10
where 0 means lack of pain, but 10 signifies un-
bearable pain — allows for determination of a de-
gree of intensity of pain. Scale is easy and simple in
employment, and it is sensitive and reliable in com-
parison with other scales of measurements of pains
[16]. Verbal scale (VRS — Verbal Rating Scale) eval-
uates pain in a descriptive manner with the aid of 5-
graded Likert’s scale).
HADS — M scale (modified HAD scale) construct-
ed by Zigmond and Snaith [17].
It is meant to serve as a method of estimation of
a level of anxiety and increase of depression in popu-
lation of sick people without psychical disturbances.
Polish authors, not changing the version of orig-
inal structure of the test, introduced two additional
positions, applying to aggression. Modification of
the questionnaire with additional scales presents a
model of negative reaction demonstrated in the form
of anxiety, depression and in difficult situation —
aggression.
Also RSCL scale was used — constructed by de
Haes (1990) for measurement of quality of life of
patients with cancer disease. The method includes
4 areas:
— scale of physical symptoms;
— scale of psychical symptoms;
— scale of a level of activity;
—  general evaluation of quality of life.
Majority of test positions is expressed as 4-point
Likert’s scale (for symptoms and level of activity).
However, general evaluation of quality of life is esti-
mated on the basis of 7-point scale of the Likerts’
type [18].
Statistical analysis
Results were statistically elaborated using t-paired
Student test and expressed as mean ± standard devi-
ation (M ± SD). Statistical differences were consid-
ered significant at p < 0.05. Statistical analysis was
carried out  using the program SAXON v. 9.1. (Cary
USA). When determining relationship among variables
studied, the Pearson’s method of correlation was used.
Results
Twelve out of thirty-four neoplastic patients
subjected to the study were men (35.3% of total)
and twenty-two were women (64.7%).Most of
them were married (18 patients, 52.9%). Nine per-
sons (26.5%) never set up family, five (14.7%) pa-
tients were widowers/widows, while 5.9% patients
(2 persons) were divorced or  in separation. Most
of studied patients (82.3%, 28 persons) inhabited
a city, and only 6 (17.6%) patients lived in village.
Most of the patients included in the study lived
on rent (18 person, 52.9%), while 8 patients
worked or were pensioners (23.5%). Estimations
of intensity of pain were carried out using( NRS)
and (VRS) scales.
Measurements were made at acceptance, af-
ter a week and after 2 weeks of treatment. For
better illustration of presented results the follow-
ing analysis was accepted: lack of pain in numeric
scale (NRS) is 0, pain of weak intensity 1–3, mod-
erate 4–6, strong 7–9, unbearable pain: 10. Suf-
fering from pain oscillated before treatment at
the level of III; (in NRS scale — pain equal to 4, 5,
6), in 61.8% in patients subjected to the study.
Gradual drop of intensity of suffered pain was
observed according to NRS scale (Figure 1) and
VRS descriptive scale (Table 1).
Distinct relationship among individual (statis-
tic significance at the level p < 0.001, average
NRS = 3.2 ± 1.8 — I period of research, average
NRS = 2.0 ± 1.6 — II period of research) stages of
research and a level of suffered pain (according
to NRS), shown in Figure 2.
Complex full estimation according to HADS — M
scale presents three categories comprising: anxiety,
depression and aggression. Results signal that de-
pression is a leading complaint (9.3 ± 5.36), which
predominates at respondents before the beginning
of treatment in the palliative care department. Anx-
iety is the next one (8.3 ± 4.98). However, we ob-
serve symptoms of aggression in an insignificantly
small group of respondents which decrease by a half
after 2 weeks of treatment  (1st period of research 2.1
± 1.87, 921; 3rd period of research 0.9 ± 1.11).
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The whole group showed a small, statistically sig-
nificant trend towards improvement in intensity of
symptoms of depression and anxiety (p < 0.05) be-
fore and after treatment.
However, important improvement was observed
(p < 0.001) in the study of symptoms of aggression
after a week and tended to persist during following
2 weeks of hospitalization.
The present work accepts standards for HADS —
M scale proposed by the authors [17] and present-
ed in Tables 2, 3 and in Figure 3.
Intensity was analyzed in the group of patients
of individual psychical symptoms contained in the
HADS — M scale.
In the first study in a half of persons no symp-
toms of anxiety were observed. Estimation of symp-
toms of depression oscillated between patients
showing no disturbances (41.2%), and group of
persons with pathological changes (38.2%).
First of all, subsequent stages of research mean
a slight decrease of pathological symptoms, in fa-
vor of patients with symptoms demonstrating a
boundary state (Figure 2 and 3).
Estimation of symptoms of aggression was per-
formed using following division points: I (high), II
(average), III (low ), IV (lack of aggression) (Figure 3).
Level of aggression fluctuated before treatment
between the group with low intensity (35.3%) and
patients without such disturbances (32.3%). Only
8.8% of respondents declared a high level of ag-
gression which has been completely eliminated dur-
ing the whole period of observation. Low levels of
aggression were maintained in subsequent stages
of the research study at 44.1% (II study) and 41.2%
Figure 1. Self-estimation of intensity of pain according to numeric scale (NRS) of estimation of pain
Table 1. Self-estimation of intensity of pain according to verbal scale (VRS) of estimation of pain
Intensity of pain Before treatment After a  week of After two weeks of
(n = 34) treatment (n = 34)  treatment (n = 34)
Very low 0 8 (23.5%) 19 (55.9%)
Moderately low 0 17 (50%) 12 (35.3%)
Unbearable 21 (61.8%) 6 (17.6%) 2 (5.9%)
Strong 9 (26.5 %) 3 (8.8%) 1 (2.9%)
High 4 (11.8 %) 0 0
Figure 2. Estimation of pain with the use of NRS scale
(n = 34)
www.advpm.eu 153
Iwona Repka, Jerzy Wordliczek, Influence of chronic pain and its treatment on quality of life
(III study). The analysis presented below supplies
important data on considerable decrease of an av-
erage level of aggression and increase of a number
of persons without aggression (after 1 week of study
47.1%, but after 2 weeks up to 55.9%).
The present work concentrates on the evalua-
tion of quality of life, using for this purpose the
Rotterdam scale of symptoms adapted for patients
in the terminal phase of their disease.
General estimation of quality of life (QOL) did not
change in 91.2% of patients in subsequent stages of
research study. Only in three cases (8.8%) it changed
and it differed before and after 2 weeks of hospital-
ization in the department of palliative care. In subse-
quent stages of research study most of patients esti-
mated their QOL as moderate (38.2%) and rather bad
(29.4%). Merely 4 persons (11.8%) estimated their
QOL as very good and 1 person (2.9%) as good in
each stage of research study. No patient estimated
quality of life as very bad. 8.8% of patients estimated
their QOL as bad before hospitalization; it improved
during the treatment and estimation of quality of life
as bad was reduced to 5.9% (Figure 4).
In the first research study general self-estima-
tion of quality of life was at the level of average. In
following research studies slight improvement was
observed and kept at the same level till the end of
hospitalization (Figure 4).
Subsequently, dynamics was compared of chang-
es of individual dimensions of quality of life accord-
ing to RSCL scale using parametric paired Student’s
t-test.
Analysis of somatic symptoms quality of life
presents important improvement (p < 0.001) with-
Table 3. Estimation of symptoms of depression in studied group using HADS  — M scale
Symptoms of Before treatment After a week of After two weeks of
depression (n = 34) treatment (n = 34)  treatment (n = 34)
Norm (lack of 14 (41.2%) 12 (35.3%) 12 (35.3%)
disturbances)
Borderline 7 (20.6%) 10 (29.4%) 11 (32.3%)
(boundary states)
Pathology 13 (38.2%) 12 (35.3%) 11 (32.3%)
(symptoms of disturbances)
Table 2.  Estimation of symptoms of anxiety in studied group using HADS — M scale
Symptoms of Before treatment After a week of After two weeks of
anxiety (n = 34) treatment (n = 34)  treatment  (n = 34)
Norm (lack of 17 (50%) 19 (55.9%) 18 (52.9%)
disturbances)
Borderline 6 (17.7%) 7 (20.6%) 9 (26.5%)
(boundary states)
Pathology 11 (32.3%) 8 (23.5%) 7 (20.6%)
(symptoms of disturbances)
Figure 3. Estimation of symptoms of aggression in studied group  using HADS — M scale
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in this dimension in the course of treatment (Fig-
ure 5).
Hospitalization in the department of palliative
care was of no significant influence on estimation
of activity in patients in terminal stage of the dis-
ease (Figure 6).
The above figure presents changes occurring in
psychical dimension in the course of treatment (II
stage of research study 46 ± 7.56; III stage of re-
search study 45.0 ± 6.93; p < 0.001) (Figure 7). The
results obtained in II stage of research study may
indicate effective application of antidepressive drugs
in nearly 15 patients (44.1%), of whom in 10 (29.4%)
tricyclic antidepressive drugs were administered, and
in 5 (14.7%) — tetracyclic antidepressive drugs.
Additionally, in 5 (14.7%) of these patients anx-
iolytics, mainly benzodiazepines, were adminis-
Figure 4. General estimation of quality of life (QOL) in RSCL scale before and in the course of treatment
Figure 5. Estimation of physical fitness according to
Rotterdam scale of symptoms (RSCL) before and in the
course of treatment. Summerized estimation (n = 34)
Figure 6. Estimation of activity in Rotterdam scale od
symptoms (RSCL) scale before and in the course of
treatment. Summerized estimation (n = 34)
Figure 7. Estimation of psychical state in Rotterdam
scale of symptoms (RSCL) before and in the course of
treatment. Summerized estimation (n = 34)
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tered. After 2 weeks of treatment a number of pa-
tients was increased to whom antidepressants
(73.5%) and anxiolytics (29.4%) were administered,
with simultaneous modifying of a dose. The dynam-
ics was analyzed of changes occurring as a result of
analgesic therapy (Figure 8). In 3 (8.8%) respondents
with pain of strong intensity VRS < = > NRS (7–9)
invasive procedures were applied, of whom in  2
(5.9%) with unbearable pain VRS < = > NRS (10).
These were patients in whom pain was not re-
duced during the whole period of treatment, de-
spite application of combination of pharmacologi-
cal drugs from the analgesic ladder. Invasive proce-
dures  lowered intensity of pain for about 2–4 de-
gree in NRS scale that shows essential effect of an-
algesic treatment [16].
In patients who before treatment in the depart-
ment of palliative care were given drugs from the
group of weak opioids (23.5%) high intensity of pain
(VRS) was observed in 5 (14.7%) of studied persons
and moderate intensity (VRS) of pain in 3 (8.8%) per-
sons. Such results may indicate application in these
patients of drugs from a wrong step of the analgesic
ladder or lack of combination with adjuvants. Admin-
istration of drugs from the group of NSAIDs was con-
tinued in only one person (2.9%) in whom pain had
was of low intensity (VRS). The above-mentioned group
of drugs in connection with adjuvants was applied in
11.8% of patients, with pain (NRS — 1–3 ).
Among patients hospitalized in the department
of palliative care mainly strong opioids and adju-
vants were administered (I stage of research study
— 41.2%, II stage of research study — 47.1%) that
resulted in quite a considerable decrease of suffered
pain (NRS 1 — 4). Almost as frequently the above
group of drugs was administered together with
NSAIDs (I stage of research study 17.6%, II stage of
research — 14.7% (Figure 8). Then, the analysis was
carried-out of relationship between intensity of pain
and individual components of quality of life.
Correlations between estimation of intensity of
pain according to NRS scale and dimensions in RSCL
scale, and components expressed in HADS — M
scale before treatment  and in the course of hospi-
talization in the department of palliative care are
presented in the Table 5. Correlation was confirmed
of psychical dimension and pain after a week and
after 2 weeks of the treatment. Estimation of in-
tensity of pain did not correlate with other dimen-
sions in RSCL scale and with negative emotions
showed in HADS — M scale in none stage of re-
search study.
Additionally, correlations were analyzed among
individual dimensions of quality of life, according
to RSCL scale, and negative emotions specified by
HADS — M scale (Figure 6).
The Table 6 shows that the statistical analysis did
not confirm significance of correlation of the level of
Table 4. General estimation of quality of life (QOL) in studied group
Before treatment After a  week of After two weeks of
(X ± SD) treatment (X ± SD)  treatment (X ± SD)
General QL 3.97 ± 1.38 3.88 ± 1.34 3.88 ± 1.34
X — mean; SD — standard deviation
Figure 8. Chosen groups of drugs used in treatment of cancer pain. 1 — lack of analgesic drugs; 2 — NSAIDs; 3 —
NSAIDs + adjuvants; 4 — weak opioids; 5 — strong opioids; 6 — weak opioids + NSAIDs; 7 — atrong opioids +
NSAIDs; 8 — strong opioids + NSAIDs +adjuvants; 9 — strong opioids + adjuvants
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activity defined according to RSCL scale with the lev-
el of anxiety, depression and psychical dimension. Also
the level of aggression according to scale HADS — M
did not correlate with any of RSCL dimensions and
other symptoms shown in HADS — M scale.
The significance was confirmed of correlation (p <
0.001) of the level of depression with the level of
anxiety in all three stages of research study.
At the same level correlation was observed be-
tween depression and physical dimension during
treatment, and psychical dimension in II stage of
research study (after a week of hospitalization). In-
side RSCL scale, relationship was observed (p <
Table 5. Correlations between  intensity of pain and individual dimensions of quality of life in chosen
periods of time
Intensity of pain estimated according to NRS scale
Research study 1 Research study 2 Research study 3
(before treatment) (after a week of treatment) (after two weeks of treatment)
Aggression  r = –0.05 p =0.74 r = 0.19 p = 0.26 r = –0.07 p = 0.66
(HADS — M)
Depression r = –0.06 p = 0.70 r = 0.03 p = 0.82 r = 0.15 p = 0.37
(HADS — M)
Anxiety r = 0.01 p = 0.95 r = 0.19 p = 0.26 r = 0.27 p = 0.11
 (HADS — M)
Activity r = 0.05 p = 0.76 r = 0.21 p = 0.21 r = –0.03 p = 0.82
(RSCL)
Somatic r = 0.23 p = 0.17 r = 0.16 p = 0.36 r = 0.30 p = 0.08
dimension
(RSCL)
Psychical r = 0.06 p = 0.69 r = 0.35 p = 0.03* r = 0.33 p = 0.04*
dimension
(RSCL)
* — value statistically significant (p < 0.05 ); r —  Pearson's correlation ratio; p —  level of significance
0.0001) between the level of activity and somatic
component. No correlation was found between ac-
tivity and psychical component. Analyzing relation-
ship between aggression and other symptoms in
HADS — M scale no statistically significant correla-
tions were found.
Discussion
In the carried-out research study the influence
was analyzed of chronic disease on quality of life.
In chronic patients an important measure be-
came a subjective evaluation of perceived wellness
Table 6. Correlations between individual components in HADS  — M scale and  RSCL scale before, after a
week and after two weeks of  treatment
RSCL RSCL RSCL HADS — M HADS — M HADS — M
(activity) (somatic) (psychical) (anxiety) (depression) (aggression)
Stages of
research I II III I II III I II III I II III I II III I II III
of study
RSCL X X X ** ** ** NS NS NS NS NS NS NS NS NS NS NS NS
(activity)
RSCL ** ** ** X X X NS NS NS NS NS NS ** * * NS NS NS
(somatic)
RSCL NS NS NS NS NS NS X X X ** ** * ** * NS NS NS NS
(psychical)
HADS — M NS NS NS NS NS NS ** ** * X X X * * * NS NS NS
(anxiety)
HADS — M NS NS NS ** * * ** * NS * * * X X X NS NS NS
(depression)
HADS — M NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS X X X
(aggression)
* — p < 0.001;   **—  p < 0.0001
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which turned out hard to evaluate, a factor which
presents a considerable lowering of quality of life.
Research confirmed improvement of quality of
life during the whole period of hospitalization, re-
lated most probably with correction of physical fit-
ness and psychical condition. Also the influence of
psychological variables turned out to be an impor-
tant element of illustration of quality of life [8, 19].
The analysis of literature indicates that conscience
of pain is a specific kind of stimulation which can-
not be defined with a single term. It is rather a
personal experience which depends on individual
psychological factors [1:12, 20:35] and causes of
pain origin. Pain presents a complex psychosomatic
process [20:35].
Differentiation between a kind and an intensity
of pain is extremely difficult and requires applica-
tion of methods which will precisely illustrate a form
of described phenomenon [20:51].
Research confirms also that a degree of intensity
of  pain complaints depends on psychical condition
of a patient [5].
Anxiety, fear, sadness as well, lower a threshold
of pain [21, 22]. Results of our own research ob-
tained using HADS — M scale prove that depres-
sion took a stand in 38.2% of studied patients (be-
fore treatment) and in 32.2% (after beginning of
treatment). Anxiety was experienced by 32.3% of
studied patients (before treatment) and 20.6% (af-
ter treatment), while aggression also accompanied
above-mentioned emotions a and it prevailed.
Before beginning of treatment, 67.6% of stud-
ied patients felt aggression, however, after 2 weeks
of hospitalization this factor was reduced to 44.1%
of them.
Proper administration  of pharmacological treat-
ment in connection with analgesic treatment con-
tributed to improvement of quality of life of pa-
tients [23].
Literature describes dependences between chron-
ic pain and depression which indicate mutual corre-
lation. Research confirms a great importance of es-
timation of intensity of pain for control of depres-
sion in the course of chronic pain [24, 17].
Depression causes increase of perceiving of somatic
complaints, especially of pain. As the authors state
[6], prolonged pain can cause difficulties in ability to
adapt in a new situation which may itself cause de-
pression [24: 223]. Lack of sense of control as well
unfavorably influences evaluation  of intensity of pain
which in consequence is perceived as strong [26].
Level of anxiety was lowered what may indicate
a good control of chronic pain and two-way depen-
dence between perception of pain and anxiety.
As the author confirms anxiety accompanying a
somatic disease is mainly an anxiety of pain, mutila-
tion and death. Anxiety combined with pain in can-
cer patients lowers to a great extent quality of life
in each stage of disease.
Both depression and anxiety quite often take a
stand together and they susally attack patients with
uncontrolled physical symptoms and biological pre-
dispositions. After treatment a decrease of nega-
tive emotions was observed. Aggression still pre-
vailed (52.9% — II research study, 44.1% — III re-
search study) in patients with cancer pains.
Life-threatening disease and its concomitant so-
matic symptoms (resulting from advanced stage of
the disease) may also cause anger, until real facts
are accepted [25]. Carried-out research confirmed
relationship among emotional state (anger) and
pain. High level of anger in patients with advanced
cancer disease generates a high intensity of chronic
pain [27, 28].
Persistence — despite treatment — of above-
mentioned feelings in a patient may indicate inef-
fective engagement of the patient in the process of
therapy and lack of control of patients’ present life
situation [28, 29].
In the course of research study in the whole popu-
lation of studied patients, improvement of indexes of
intensity of pain were observed. Changes were associ-
ated with gradual improvement of quality of life.
It is possible that a worse general evaluation of
quality of life in terminal patients is influenced by
other factors, not associated with factors analyzed
in the discussed research study.
It is important that therapeutic procedures of
care over terminal patients with chronic pain were
based on recommendations of International Asso-
ciation For the Study of Pain which approach the
problems of pain in a multi-directional manner and
take many aspects into consideration (according to
holistic attitude Melzack and Wall’s [1: 4]), in order
to improve care and quality of life [30].
Conclusions
1. There exists a relationship between intensity of
pain according to NRS scale with psychical di-
mension during treatment in the department of
palliative care.
2. Significant lowering of pain complaints in the
course of treatment proves correctness of anal-
gesic procedure.
3. Obtained results show complexity of interrela-
tion between cancer pain and individual dimen-
sions of quality of life.
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